Literature DB >> 7609597

Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: kinetics of apoprotein changes.

S H Zuckerman1, G F Evans.   

Abstract

Inhibition of cholesteryl ester transfer protein (CETP) activity in hypercholesterolemic hamsters results in elevated high-density lipoprotein (HDL) cholesterol, an increase in HDL size, and the appearance of apolipoprotein E (apo E)-rich, apo A-I-poor particles. The present study has focused on the kinetics of apoprotein redistribution among the HDL particles and the relative increase in HDL-associated apo E and CETP in hypercholesterolemic hamsters, following inhibition of transfer activity using the monoclonal antibody, TP2. A 60% inhibition in CETP activity was observed 24 h after antibody injection and was associated with an increase in HDL cholesterol and HDL size. Increased amounts of apo E were associated with these HDL particles and remained in this fraction throughout the duration of the study. In contrast, while CETP was also detected on large HDL particles, this distribution shifted back toward the pretreatment pattern by 14 d. The dynamic changes in apoprotein distribution may represent a compensatory physiologic response following disruption of reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609597     DOI: 10.1007/BF02536037

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  29 in total

Review 1.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Effects of blocking plasma lipid transfer protein activity in the rabbit.

Authors:  M Abbey; G D Calvert
Journal:  Biochim Biophys Acta       Date:  1989-05-15

4.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

5.  Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia.

Authors:  P Moulin; G B Appel; H N Ginsberg; A R Tall
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

7.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.

Authors:  K R Marotti; C K Castle; T P Boyle; A H Lin; R W Murray; G W Melchior
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

8.  Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein.

Authors:  M Kinoshita; H Arai; M Fukasawa; T Watanabe; K Tsukamoto; Y Hashimoto; K Inoue; K Kurokawa; T Teramoto
Journal:  J Lipid Res       Date:  1993-02       Impact factor: 5.922

9.  Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence.

Authors:  E M Quinet; P Huerta; D Nancoo; A R Tall; Y L Marcel; R McPherson
Journal:  J Lipid Res       Date:  1993-05       Impact factor: 5.922

10.  Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins.

Authors:  C L Bisgaier; M V Siebenkas; C B Hesler; T L Swenson; C B Blum; Y L Marcel; R W Milne; R M Glickman; A R Tall
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

View more
  1 in total

1.  Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.

Authors:  Eric J Niesor; Christine Magg; Naoto Ogawa; Hiroshi Okamoto; Elisabeth von der Mark; Hugues Matile; Georg Schmid; Roger G Clerc; Evelyne Chaput; Denise Blum-Kaelin; Walter Huber; Ralf Thoma; Philippe Pflieger; Makoto Kakutani; Daisuke Takahashi; Gregor Dernick; Cyrille Maugeais
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.